Cargando…

Ag85B synergizes with ESAT-6 to induce efficient and long-term immunity of C57BL/6 mice primed with recombinant Bacille Calmette-Guerin

The latest probable scenario in vaccination strategies is to prime one live attenuated vaccine candidate followed by boost dose of second vaccine candidate. In the present study, we primed the mice with a recombinant Bacille Calmette-Guerin (BCG) comprising Ag85B and ESAT-6 followed by boost doses o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Wei, Xu, Ying, Yan, Jingran, Shen, Hongbo, Yang, Enzhuo, Wang, Honghai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5245152/ https://www.ncbi.nlm.nih.gov/pubmed/28123491 http://dx.doi.org/10.3892/etm.2016.3944

Ejemplares similares

Recombinant Bacille Calmette-Guérin coexpressing Ag85B-IFN-γ enhances the cell-mediated immunity in C57BL/6 mice
por: Liu, Wei, et al.
Publicado: (2017)

Bacille Calmette-Guérin: An ophthalmic perspective
por: Jain, Manish, et al.
Publicado: (2022)

Are Bacille Calmette-Guérin Skin Reactions the Most Important Correlates of Bacille Calmette-Guérin’s Specific and Nonspecific Effects?
por: Schaltz-Buchholzer, Frederik
Publicado: (2022)

Tuberculosis vaccines: beyond bacille Calmette–Guérin
por: McShane, Helen
Publicado: (2011)

Gluteal abscess: An unusual complication of Bacille Calmette-Guérin
por: Buyukoglan, Hakan, et al.
Publicado: (2011)

Bacille-Calmette-Guerin non-responders: how to manage
por: von Rundstedt, Friedrich-Carl, et al.
Publicado: (2015)

Sleeping Beauty and the Story of the Bacille Calmette-Guérin Vaccine
por: Fletcher, Helen A.
Publicado: (2016)

Next-Generation Vaccines Based on Bacille Calmette–Guérin
por: Nieuwenhuizen, Natalie E., et al.
Publicado: (2018)

Determinants of Bacille Calmette-Guérin scarification in Danish children
por: Jensen, Trine Mølbæk, et al.
Publicado: (2021)

Revaccination with Bacille Calmette-Guérin: Some issues to consider
por: Datta, Manjula, et al.
Publicado: (2023)

Combination of Intravesical Bacille Calmette-Guérin and Chemotherapy vs. Bacille Calmette-Guérin Alone in Non-muscle Invasive Bladder Cancer: A Meta-Analysis
por: Huang, Di, et al.
Publicado: (2019)

Penile tuberculosis following intravesical Bacille Calmette-Guérin immunotherapy
por: Chowdhury, Anadi Roy, et al.
Publicado: (2013)

Bacille Calmette–Guérin dosage; challenging dogmas and changing paradigms
por: Mansour, Ahmed M.
Publicado: (2015)

Management and outcome of Bacille Calmette-Guérin vaccine adverse reactions
por: Venkataraman, Aishwarya, et al.
Publicado: (2015)

Mycobacterium bovis Bacille-Calmette-Guérin Infection Aggravates Atherosclerosis
por: Huaman, Moises A., et al.
Publicado: (2020)

Will bacille Calmette-Guerin immunization arrest the COVID-19 pandemic?
por: Ehtesham, Nasreen Zafar, et al.
Publicado: (2020)

Disseminated Bacille Calmette-Guérin disease in immunocompetent adult patients
por: Nascimento, Luísa, et al.
Publicado: (2016)

Identification of N(6),N(6)-Dimethyladenosine in Transfer RNA from Mycobacterium bovis Bacille Calmette-Guérin
por: Chan, Clement T.Y., et al.
Publicado: (2011)

Tuberculous Orchitis Following Intravesical Bacille Calmette-Guérin (BCG) Therapy
por: Klebanov, Nikolai, et al.
Publicado: (2018)

Bacille Calmette-Guérin Vaccination in Saudi Arabia: Benefits versus Risks
por: Al Jumaah, Suliman, et al.
Publicado: (2012)

3280 Mycobacterium bovis Bacille-Calmette-Guérin infection aggravates atherosclerosis
por: Huaman, Moises, et al.
Publicado: (2019)

Tuberculous Spondylitis after Intrarenal Bacille Calmette-Guerin (BCG) Therapy
por: Kajihara, Yusaku, et al.
Publicado: (2019)

The safety of co-administration of Bacille Calmette-Guérin (BCG) and influenza vaccines
por: Villanueva, Paola, et al.
Publicado: (2022)

Guillain Barré syndrome associated with bladder instillation of Bacille Calmette Guérin (BCG)
por: Webb, Karmel, et al.
Publicado: (2018)

Mycobacterial Arthritis at 19 Months After a Bacille Calmette–Guérin Vaccination
por: Lin, Chien-Yu, et al.
Publicado: (2017)

Mycobacterium bovis Osteitis Following Immunization with Bacille Calmette-Guérin (BCG) in Korea
por: Choi, Youn Young, et al.
Publicado: (2018)

Nicotinamide Limits Replication of Mycobacterium tuberculosis and Bacille Calmette-Guérin Within Macrophages
por: Simmons, Jason D, et al.
Publicado: (2020)

Papulonecrotic tuberculid caused by Bacille Calmette-Guerin vaccination requiring no antitubercular agents
por: Araki, Kotaro, et al.
Publicado: (2020)

Effects of Bacille Calmette Guerin (BCG) vaccination during COVID-19 infection
por: Chowdhury, Utpala Nanda, et al.
Publicado: (2021)

Spinal Tuberculosis Secondary to Intravesical Bacille Calmette-Guerin Treatment for Bladder Cancer
por: Yergin, Celeste G, et al.
Publicado: (2021)

Immunotherapy of COVID-19 with Bacille Calmette – Guerin: Where is the missing red herring?
por: Saxena, Hari M.
Publicado: (2021)

Revaccination with Bacille Calmette-Guérin (BCG) is associated with an increased risk of abscess and lymphadenopathy
por: Villanueva, Paola, et al.
Publicado: (2022)

The Association Between Bacille Calmette-Guérin Vaccination and Nontuberculous Mycobacterial Pulmonary Disease
por: Kwak, Nakwon, et al.
Publicado: (2022)

Factors influencing scar formation following Bacille Calmette-Guérin (BCG) vaccination
por: Villanueva, Paola, et al.
Publicado: (2023)

Bacille Calmette–Guerin Scar Reactivation: A Sign to Suggest Kawasaki Disease
por: Sharma, Avinash, et al.
Publicado: (2023)

Factors influencing scar formation following Bacille Calmette-Guérin (BCG) vaccination
por: Villanueva, Paola, et al.
Publicado: (2023)

Immunologic aspects of patients with disseminated bacille Calmette-Guerin disease in north-west of Iran
por: Sadeghi-Shanbestari, Mahnaz, et al.
Publicado: (2009)

The impact of maternal infection with Mycobacterium tuberculosis on the infant response to bacille Calmette–Guérin immunization
por: Mawa, Patrice A., et al.
Publicado: (2015)

Bacille Calmette–Guerin Complications in Newly Described Primary Immunodeficiency Diseases: 2010–2017
por: Nunes-Santos, Cristiane de Jesus, et al.
Publicado: (2018)

The Recombinant Bacille Calmette–Guérin Vaccine VPM1002: Ready for Clinical Efficacy Testing
por: Nieuwenhuizen, Natalie E., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_5jn4nb3lvohl8b7htmtcdkvmvp